Dr. Haigentz's research focuses on the development of clinical trials for the treatment of aerodigestive (lung and head and neck) cancers, and his work has taken a particular focus on these cancers in persons with HIV infection. Dr. Haigentz received the American Society of Clinical Oncology (ASCO) Career Development Award in 2004 and NIH funding for his research in head and neck cancer. He chairs the Non-AIDS Defining Cancer Working Group of the AIDS Malignancy Consortium and has served on several committees supported by the National Cancer Institute. Additional honors include service on the Editorial Board of the Journal of Clinical Oncology and as 2014-2015 President of the New York Head and Neck Society.
At the completion of this educational session, learners will:
- Appreciate the changing epidemiology of cancer in the era of combination antiretroviral therapy.
- Understand reasons for cancer care disparities in this population.
- Be aware of current challenges in cancer care (prevention, screening and treatment), focusing on lung cancer, for persons with HIV infection.
- Know about current clinical trials for patients with non-AIDS defining cancers.
This CME activity was approved for AMA PRA Category 1 Credit™
on September 8, 2015 and will terminate September, 2018.
The target audience is all physicians, NPs and PAs involved or interested in HIV education.
This online video and post-activity evaluation are one hour in length.
After you complete the video portion of this educational activity there will be a post-activity evaluation and quiz.
You must achieve at least 70% correct to receive your CME certificate.
If successful, you will be provided instructions to print your CME certificate at the completion of this activity.
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the Medical Society of the State of New York (MSSNY) and the Physicians’ Research Network (PRN). MSSNY is accredited by the ACCME to provide continuing medical education for physicians.
The Medical Society of the State of New York designates this enduring material for a maximum of 1.0 AMA PRA Category 1 Credit™
. Physicians should claim only the credit commensurate with extent of their participation in the activity.
Policies and standards of MSSNY require that speakers and planners for CME activities disclose any relevant financial relationships they may have with commercial interests whose products, devices or services may be discussed in the content of a CME activity.
Dr. James Braun (Planner/Course Director) had no relevant financial relationships to disclose.
Dr. Missak Haigentz (Presenter) had no relevant financial relationships to disclose. Dr. Haigentz submitted his slides in advance for adequate peer review, and will support his presentation and clinical recommendations with the best available evidence from the medical literature.
This PRN CME activity is funded in part by unrestricted educational grants from:
Bristol-Myers Squibb, Gilead Sciences, Merck & Co, and ViiV Healthcare.
To obtain CME credit for this and other PRN programs, please visit the PRN Courses page
at the Clinical Education Initiative (CEI) web site. PRN and the Medical Society of the State of New York (MSSNY) jointly sponsor PRN enduring materials for CME, and provide them at no cost to the AIDS Institute of the New York State Department of Health (NYSDOH) for broadcast through the CEI. We thank the NYSDOH for making our CME programs available to a wider audience, and hope you will also browse the many other educational opportunities offered by the CEI.